Wednesday, May 31, 2017 -- When Jill was 27, she woke up with tingling and numbness in her left hand that eventually spread to half her body. The Calgary woman, who did not want her last name used for fear it could hinder her future employment, went for tests and was told there was a possibility she would develop multiple...
Friday, May 26, 2017 -- Curology is a dermatology startup that treats patients via the web and delivers personalized prescriptions to their homes.
Sunday, September 03, 2017 -- Blue light therapy is an FDA-approved, non-invasive phototherapy treatment for acne. Light in the blue wavelength is used to kill acne-causing bacteria.
Friday, October 20, 2017 -- The skin solution is made with cannabidiols – natural compounds found in cannabis that have anti-inflammatory properties.
Saturday, June 24, 2017 -- (MedPage Today) -- Also, coffee lowers melanoma risk
Friday, July 28, 2017 -- Sebacia Inc., which is based in Duluth, Ga., is developing a topical formulation that uses laser-activated microparticles to treat moderate to severe acne. Sebacia intends to use the Series D financing to complete a U.S. pivotal trial.
Thursday, June 15, 2017 -- (MedPage Today) -- New study reveals link between microbes and acne
Friday, May 26, 2017 -- A recent study addresses the common occurrence of acne vulgaris, and reviews various types of fillers for acne including temporary, semi-permanent, and permanent dermal fillers. Acne vulgaris is a common skin condition affecting primarily the face, back, and neck. It affects approximately 80% of adolescents and subsequent scarring is a prominent concern for these […] The post Dermal Fillers: An Effective Treatment for Acne appeared first on Medical News Bulletin.
Tuesday, June 06, 2017 -- Study results offer safe and affordable treatment option.A Canadian clinical trial led by researchers at the University of Calgary's Hotchkiss Brain Institute (HBI), at the Cumming School of...
Sunday, November 12, 2017 -- (MedPage Today) -- Few studies to confirm risk, but guidelines discourage monotherapy with antimicrobials
Friday, July 07, 2017 -- With cash dwindling, Morrisville-based Novan (Nasdaq: NOVN) is continuing to push forward with its nitric-oxide based acne product SB204 on the heels of a leadership change and workforce reduction. Earlier this year, the company announced mixed Phase 3 clinical trial results for SB204, which sent its stock plummeting 75 percent. Shortly thereafter, Novan said it had assembled a team to analyze the data from those trials and that it continues to remain optimistic on the product and a pre-submission…
Tuesday, October 03, 2017 -- Particular foods have historically been implicated in the development of severe acne. But is there a valid correlation between the type of diet and the development of acne in adults? Acne is caused by an inflammation of the hair follicles and oil-producing glands, which are in greater distribution along the face, neck, and back areas. […] The post Zits and What You Eat: Does Diet Cause Severe Acne? appeared first on Medical News Bulletin.
Tuesday, July 25, 2017 -- US company Sebacia raises $36M in debt and equity finance; trial results anticipated next year.
Thursday, October 12, 2017 -- Public healthcare provider plans to offload eight of their 77 U.S. hospitals, an effort expected to yield $900 million to $1 billion.
Saturday, October 14, 2017 -- (MedPage Today) -- Consent laws not clear with respect to minors and oral contraceptive pills
Saturday, October 28, 2017 -- (MedPage Today) -- Biggest impact likely for patients with darker skin types
Thursday, August 03, 2017 -- Foamix Pharmaceuticals announced that the first patient has been dosed in its third phase 3 study to measure the efficacy and safety of FMX101, its topical minocycline foam 4%, in patients with moderate-to-severe acne."During a recent Type B meeting, the FDA confirmed that statistically significant findings from a third study would constitute replication of the Study FX2014-05 results, and would be sufficient to establish an efficacy claim,” David Domzalski, CEO of Foamix, stated in a news release. “This confirmation supports our plans for conducting a third phase 3 study.”
Friday, June 02, 2017 -- Instead of re-surfacing the surrounding areas, doctors are now looking at numerous substances that can act as fillers to address acne scars caused by acne. While many chemical fillers have been proposed, there is currently only one that has been approved by the FDA, and evidence remains inconclusive. Acne has been the scourge of […] The post Acne Scars and Fillers: Can They Fill in the Gap? appeared first on Medical News Bulletin.
Friday, January 12, 2018 -- NewsThe FDA accepted Ortho Dermatologics' NDA filing for IDP-121 (tretinoin 0.05%) acne treatment in lotion form. If approved, it will be the first tretinoin product in lotion form rather than a gel or cream.Contributed Author: Valeant Pharmaceuticals International, Inc.Topics: Drug Development
Thursday, December 14, 2017 -- by Kiyong Na, Sang Ho Oh, Sang Kyum Kim Acne keloidalis nuchae, a type of folliculitis involving the back of the neck, is common in black men, although rare cases have been reported in patients of other ethnicities. We analyzed the clinicopathological features of acne keloidalis nuchae in 17 Asians. Patients’ age at the time of presentation ranged from 20 to 69 years. Most patients experienced the disease over 2 years (range, 3 months–20 years); follow-up data were available for 11 (65%) patients (range, 2–95 months). Nine (53%) patients had comorbidities, but none had a history of other skin disease or a family history of acne keloidalis nuchae. Macroscopically, seven (41%) patients had multiple erythematous pustulopapular lesions, and 10